So Hun Kim

Dr. So Hun Kim

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in International Journal of Nursing Studies
Verified
Journal Article
Closed access
ELEun-Hyun Lee
Eun-Hyun Lee
YLYoung Whee Lee
Young Whee Lee
KLKwan-Woo Lee
Kwan-Woo Lee
MNMoonsuk Nam
Moonsuk Nam
SKSo Hun Kim
So Hun Kim

26 January 2022 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
DSDa Hea Seo
Da Hea Seo
YSYoung Ju Suh
Young Ju Suh
YCYongin Cho
Yongin Cho
SASeong Hee Ahn
Seong Hee Ahn
SSSeongha Seo
Seongha Seo
SKSo Hun Kim
So Hun Kim
Background: Nonalcoholic fatty liver disease (NAFLD) is associated with chronic kidney disease (CKD). However, the causal relationship between NAFLD and CKD is uncertain, particularly in patients with type 2 diabetes mellitus (T2DM). We aimed to investigate the association between the presence and severity of NAFLD and incident CKD in patients with T2DM.Methods: In this longitudinal cohort study of patients with T2DM, 3,188 patients with preserved renal function were followed up for the occurrence of incident CKD. NAFLD was defined as the presence of hepatic steatosis on ultrasonography, without any other causes of chronic liver disease. Advanced liver fibrosis of NAFLD was defined as a fibrosis-4 index ≥2.67. CKD was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m2.Results: At baseline, 1,729 (54.2%) patients had NAFLD, of whom 94 (5.4%) had advanced liver fibrosis. During the follow-up of 8.3±3.6 years, 472 (14.8%) patients developed incident CKD: 220 (15.1%) in the non-NAFLD group, 231 (14.1%) in the NAFLD without advanced fibrosis group and 28 (31.1%) in the NAFLD with advanced fibrosis group. There was no increased risk of incident CKD in the NAFLD group compared to the non-NAFLD group (P=0.435). However, among patients with NAFLD, advanced liver fibrosis was associated with an increased risk of CKD (adjusted hazard ratio, 1.75; 95% confidence interval, 1.15 to 2.66; P=0.009).Conclusion: Advanced liver fibrosis in patients with NAFLD is independently associated with an increased risk of incident CKD in patients with T2DM.

6 March 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HPHye-Sun Park
Hye-Sun Park
YCYongin Cho
Yongin Cho
DSDa Hea Seo
Da Hea Seo
SASeong Hee Ahn
Seong Hee Ahn
SHSeongbin Hong
Seongbin Hong
SKSo Hun Kim
So Hun Kim
The effect of diabetes distress on glycemic control and its association with diabetes complications is still poorly understood. We aimed to study the clinical features of patients with high diabetes distress, focusing on changes in glycemic control and risk of diabetic complications. From the Korean National Diabetes Program data, we investigated 1862 individuals with type 2 diabetes mellitus (T2DM) who completed diabetic complication studies and the Korean version of the Problem Areas in Diabetes Survey (PAID-K). A total score of PAID-K ≥ 40 was considered indicative of high distress. Individuals with high distress (n = 589) had significantly higher levels of glycated hemoglobin than those without distress (7.4% vs. 7.1%, p < 0.001). This trend persisted throughout the 3-year follow-up period. Higher PAID-K scores were associated with younger age, female gender, longer duration of diabetes, and higher carbohydrate intake (all p < 0.05). There was a significant association between high distress and diabetic neuropathy (adjusted odds ratio, 1.63; p = 0.002), but no significant association was found with other complications, including retinopathy, albuminuria, and carotid artery plaque. In conclusion, high diabetes distress was associated with uncontrolled hyperglycemia and higher odds of having diabetic neuropathy.

19 September 2022 in Diabetes & Metabolism
Verified
Journal Article
Closed access
YCYongin Cho
Yongin Cho
HPHye-Sun Park
Hye-Sun Park
BHByung Wook Huh
Byung Wook Huh
SSSeong Ha Seo
Seong Ha Seo
DSDa Hea Seo
Da Hea Seo
SKSo Hun Kim
So Hun Kim

1 October 2020 in Diabetes & Metabolism
Verified
Journal Article
Closed access
DSD.H. Seo
D.H. Seo
YLYong-ho Lee
Yong-ho Lee
SPS.W. Park
S.W. Park
YCY.J. Choi
Y.J. Choi
BHB.W. Huh
B.W. Huh
BCBong-Soo Cha
Bong-Soo Cha

1 July 2020 in Atherosclerosis
Verified
Journal Article
Closed access
DSDa Hea Seo
Da Hea Seo
YLYong-Ho Lee
Yong-Ho Lee
YSYoung Ju Suh
Young Ju Suh
SASeong Hee Ahn
Seong Hee Ahn
SHSeongbin Hong
Seongbin Hong
SKSo Hun Kim
So Hun Kim